Today’s dynamic market scenario demands that you closely track your customers, in order to boost your engagement strategy, identify potential opportunities and mitigate business risks.
Cello Health has developed a suite of syndicated offerings tailored to support your strategic objectives at key stages in the product lifecycle. Our customisable group of reports will provide regular actionable insights from market landscape maps based on social media data, as well as ongoing tracking of HCP preferences and channel behaviour.
One of our latest offerings is Sonar. Based on social media and digital data sources, Sonar offers regular comprehensive market reports focused on therapeutic areas, industry trends, events and conferences. For more information on Sonar, click here.
To register interest and to get more information when it becomes available, please click here
Introducing Sonar – a new syndicated offer from Cello Health
The US Forecaster’s Check List for Japan: A World of Difference
Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls. Doug Willson, Senior Vice President, Cello Health Advantage and Tiffany Ahlers, Chief Commercial Officer, Mycovia Pharmaceuticals Inc., share a checklist to improve the rigor and validity of product forecasts for Japan.
Using organic and unfiltered social media data, Cello Health is proud to share with you the first in a series of reports aimed at centralizing and amplifying the authentic patient experience.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us